JPS5951296A - モノサツカライド誘導体 - Google Patents
モノサツカライド誘導体Info
- Publication number
- JPS5951296A JPS5951296A JP57160408A JP16040882A JPS5951296A JP S5951296 A JPS5951296 A JP S5951296A JP 57160408 A JP57160408 A JP 57160408A JP 16040882 A JP16040882 A JP 16040882A JP S5951296 A JPS5951296 A JP S5951296A
- Authority
- JP
- Japan
- Prior art keywords
- compound
- formula
- reacting
- fatty acid
- hydroxyl group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000002771 monosaccharide derivatives Chemical class 0.000 title claims description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 10
- 125000005313 fatty acid group Chemical group 0.000 claims abstract description 4
- 150000001875 compounds Chemical class 0.000 abstract description 12
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract description 6
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 abstract description 6
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 abstract description 3
- 125000005480 straight-chain fatty acid group Chemical group 0.000 abstract description 3
- 208000035473 Communicable disease Diseases 0.000 abstract description 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 abstract description 2
- 239000002246 antineoplastic agent Substances 0.000 abstract description 2
- 238000000034 method Methods 0.000 abstract description 2
- -1 triethyl-oxonium tetrafluoroborate Chemical compound 0.000 abstract description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 230000003449 preventive effect Effects 0.000 abstract 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 abstract 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 12
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 11
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 6
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 229940104230 thymidine Drugs 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 230000002297 mitogenic effect Effects 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 229940125904 compound 1 Drugs 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 2
- CIZOCKPOEXXEHB-CQSZACIVSA-N (3r)-tetradecan-3-ol Chemical compound CCCCCCCCCCC[C@H](O)CC CIZOCKPOEXXEHB-CQSZACIVSA-N 0.000 description 1
- RNHDAKUGFHSZEV-UHFFFAOYSA-N 1,4-dioxane;hydrate Chemical compound O.C1COCCO1 RNHDAKUGFHSZEV-UHFFFAOYSA-N 0.000 description 1
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 125000003047 N-acetyl group Chemical group 0.000 description 1
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 1
- 108010021119 Trichosanthin Proteins 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 238000010531 catalytic reduction reaction Methods 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-O ethanol;hydron Chemical compound CC[OH2+] LFQSCWFLJHTTHZ-UHFFFAOYSA-O 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229940084947 glutose Drugs 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 210000004324 lymphatic system Anatomy 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000003226 mitogen Substances 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57160408A JPS5951296A (ja) | 1982-09-14 | 1982-09-14 | モノサツカライド誘導体 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57160408A JPS5951296A (ja) | 1982-09-14 | 1982-09-14 | モノサツカライド誘導体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5951296A true JPS5951296A (ja) | 1984-03-24 |
| JPH0211598B2 JPH0211598B2 (enrdf_load_stackoverflow) | 1990-03-14 |
Family
ID=15714286
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP57160408A Granted JPS5951296A (ja) | 1982-09-14 | 1982-09-14 | モノサツカライド誘導体 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5951296A (enrdf_load_stackoverflow) |
-
1982
- 1982-09-14 JP JP57160408A patent/JPS5951296A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0211598B2 (enrdf_load_stackoverflow) | 1990-03-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS59501906A (ja) | ガラクトサミン―ウロン酸基本単位（モチーフ）を含むオリゴ糖類の有機合成法 | |
| CA1041488A (en) | Process for the preparation of analogues of daunomycin | |
| CA1236831A (en) | .alpha.,.alpha.-TREHALOSE FATTY ACID DIESTER DERIVATIVE AND PREPARATION PROCESS THEREOF | |
| WO1999026640A1 (en) | Pharmaceutical composition containing extracts of cervus nippon antlers having growth-stimulating activities of hematopoietic stem cells and megakaryocytes | |
| WO2020000788A1 (zh) | 一种酯化硒多糖及其制备方法和应用 | |
| JPS60260590A (ja) | 新規オリゴ糖類ならびにこれらの合成方法および生物学的用途 | |
| JPH0582393B2 (enrdf_load_stackoverflow) | ||
| EP0267297B1 (en) | Sialosylcholesterol, process for its preparation, and drug for treating diseases of nervous system | |
| JPS5951296A (ja) | モノサツカライド誘導体 | |
| CA1269369A (en) | Derivatives of the oligosaccharide antibiotic complex 13-384, their preparation and pharmaceutical compositions containing them | |
| US4447600A (en) | N-Acetylneuraminic acid derivatives and the preparation thereof | |
| CN119139331A (zh) | 唾液酸酯的用途 | |
| CN1129223A (zh) | 1-n-乙基紫苏霉素的制备方法 | |
| JPH0211597B2 (enrdf_load_stackoverflow) | ||
| CN109232646B (zh) | 一种三氮唑类脲酶抑制剂型饲料添加剂及其制备方法 | |
| JPH0560474B2 (enrdf_load_stackoverflow) | ||
| CN100488977C (zh) | 化学合成法生产胞苷的工艺 | |
| CN1058722C (zh) | 一种新型重金属促排剂的制备方法及其用于治疗和预防重金属中毒的用途 | |
| JP4993844B2 (ja) | コンドロイチン又はコンドロイチン誘導体の製造法 | |
| IE46122B1 (en) | Antitumour glycosides | |
| CN115433247B (zh) | 一种阿拉伯半乳聚糖核心四糖片段的合成方法 | |
| JPS6311359B2 (enrdf_load_stackoverflow) | ||
| Verberckmoes et al. | Synthesis and Biological Evaluation of Some D-Xylofuranosyl-Pyridine C-Nudeosides | |
| JPS6219598A (ja) | ２，３，２′，３′−テトラ−Ｏ−アルキル−α，α−トレハロ−ス誘導体 | |
| JP3242472B2 (ja) | 新規な癌細胞転移抑制物質６−（トリフロロアセタミド）−４，５−ジヒドロキシピペリジン−３−カルボン酸およびその製造法 |